CT测量的心包脂肪而非肝脏脂肪与心血管结局和结构相关:动脉粥样硬化多种族研究
研究纳入4234名MESA参与者,评估心包脂肪体积和肝脏脂肪(CT衰减)与心血管事件及心脏重构的关系。中位随访12.2年,心包脂肪与硬性动脉粥样硬化性心血管病风险升高相关(标准化HR 1.22),而肝脏脂肪无显著关联。心包脂肪还与左心室质量及向心性重构相关。
要点
- 心包脂肪体积每增加1个标准差,硬性ASCVD风险升高(标准化HR 1.22,95%CI 1.10-1.35)。
- CT测量的肝脏脂肪与硬性ASCVD无显著关联(标准化HR 0.96,95%CI 0.86-1.08)。
- 心包脂肪最高四分位组较低四分位组左心室质量指数更高(37.8 vs 33.9 g/m2.7)。
核心结论
- 心包脂肪与较差的心血管疾病预后和左心室重构相关,独立于胰岛素抵抗、炎症和CT测量的肝脏脂肪。
研究设计与样本
- 研究类型为MESA(动脉粥样硬化多种族研究)队列分析,样本量4234名参与者,同时具有心脏磁共振和CT测量心包脂肪体积及肝脏衰减。
诊断标准与关键数值
- 心包脂肪与硬性ASCVD的标准化HR为1.22(95%CI 1.10-1.35,p=0.0001)。
- 肝脏脂肪与硬性ASCVD的标准化HR为0.96(95%CI 0.86-1.08,p=0.52)。
- 心包脂肪最高四分位组与最低四分位组比较:左心室质量指数37.8 g/m2.7 vs 33.9 g/m2.7(p<0.01),左心室质量/容积比1.2 vs 1.1(p<0.01)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The study sought to determine the associations between local (pericardial) fat and incident cardiovascular disease (CVD) events and cardiac remodeling independent of markers of overall adiposity.
BACKGROUND: The impact of pericardial fat-a local fat depot encasing the heart-on myocardial function and long-term CV prognosis independent of systemic consequences of adiposity or hepatic fat is an area of active debate.
METHODS: We studied 4,234 participants enrolled in the MESA (Multi-Ethnic Study of Atherosclerosis) study with concomitant cardiac magnetic resonance imaging and computed tomography (CT) measurements for pericardial fat volume and hepatic attenuation (a measure of liver fat). Poisson and Cox regression were used to estimate the annualized risk of incident hard atherosclerotic CVD (ASCVD), all-cause death, heart failure, all-cause CVD, hard coronary heart disease, and stroke as a function of pericardial and hepatic fat. Generalized additive models were used to assess the association between cardiac magnetic resonance indices of left ventricular (LV) structure and function and pericardial fat. Models were adjusted for relevant clinical, demographic, and cardiometabolic covariates.
RESULTS: MESA study participants with higher pericardial and hepatic fat were more likely to be older, were more frequently men, and had a higher prevalence of cardiometabolic risk factors (including dysglycemia, dyslipidemia, hypertension), as well as adiposity-associated inflammation. Over a median 12.2-year follow-up (interquartile range: 11.6 to 12.8 years), pericardial fat was associated with a higher rate of incident hard ASCVD (standardized hazard ratio: 1.22; 95% confidence interval: 1.10 to 1.35; p = 0.0001). Hepatic fat by CT was not significantly associated with hard ASCVD (standardized hazard ratio: 0.96; 95% confidence interval: 0.86 to 1.08; p = 0.52). Higher pericardial fat was associated with greater indexed LV mass (37.8 g/m2.7 vs. 33.9 g/m2.7, highest quartile vs. lowest quartile; p < 0.01), LV mass-to-volume ratio (1.2 vs. 1.1, highest quartile vs. lowest quartile; p < 0.01). In adjusted models, a higher pericardial fat volume was associated with greater LV mass (p < 0.0001) and concentricity (p < 0.0001).
CONCLUSIONS: Pericardial fat is associated with poorer CVD prognosis and LV remodeling, independent of insulin resistance, inflammation, and CT measures of hepatic fat.
引用
- Shah RV, Anderson A, Ding J, et al. Pericardial, But Not Hepatic, Fat by CT Is Associated With CV Outcomes and Structure: The Multi-Ethnic Study of Atherosclerosis. JACC Cardiovasc Imaging. 2017. PMID: 28330662. doi:10.1016/j.jcmg.2016.10.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。